Canine atopic dermatitis is one of the most common chronic diseases in dogs, causing persistent itching, skin damage, and reduced quality of life requiring long-term management.
Canine atopic dermatitis causes significant chronic welfare compromise through relentless pruritus that disrupts sleep, normal behavior, and social interaction. Secondary skin infections and otitis add painful complications to baseline discomfort. Modern biologics provide effective long-term itch control that dramatically improves quality of life for many atopic dogs. Allergen-specific immunotherapy through hyposensitization offers potential long-term improvement by addressing underlying immune dysregulation. Early diagnosis and proactive management prevents the welfare burden of undertreated chronic itch.